New signaling routes for an old drug: Lipoxin A4 might mediate heme oxygenase-1 induction by aspirin. Focus on "Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells"

American Journal of Physiology - Cell Physiology

Volumn 289, Issue 3 58-3, 2005, Pages

  Schröder, Henning ^a,b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEME OXYGENASE 1; LIPOXIN A;

ANTIOXIDANT ACTIVITY; DRUG MECHANISM; EDITORIAL; ENZYME INDUCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULARIZATION;

ANIMALS; ASPIRIN; CYCLOOXYGENASE INHIBITORS; ENDOTHELIAL CELLS; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; LIPOXINS; MEMBRANE PROTEINS; SIGNAL TRANSDUCTION;

EID: 23944458074     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00230.2005     Document Type: Editorial

References (21)

1. Alam J, Igarashi K, Immenschuh S, Shibahara S, and Tyrrell RM. Regulation of heme oxygenase-1 gene transcription: recent advances and highlights from the International Conference (Uppsala, 2003) on Heme Oxygenase. Antiox Redox Signal 6: 924-933, 2004.
2. Bainbridge SA and Smith GN. HO in pregnancy. Free Radic Biol Med 38: 979-988, 2005.
3. Becker JC, Grosser N, Schröder H, Domschke W, and Pohle T. Gastroprotection by vitamin C-a heme oxygenase-dependent mechanism? Biochem Biophys Res Commun 312: 507-512, 2003.
4. Berndt G, Grosser N, Hoogstraate J, and Schröder H. AZD3582 increases heme oxygenase-1 expression and antioxidant activity in vascular endothelial and gastric mucosal cells. Eur J Pharm Sci 25: 229-235, 2005.
5. Claria J and Serhan CN. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 92: 9475-9479, 1995.
6. Duley L, Henderson-Smart D, Knight M, and King J. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ 322: 329-33, 2001.
7. Exner M, Minar E, Wagner O, and Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 37: 1097-1104, 2004.
8. Fries JF, Williams CA, and Bloch DA. The relative toxicity of nonsteroidal antiinflammatory drugs. Arthritis Rheum 34: 1353-1360, 1991.
9. Grosser N and Schröder H. Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway. Arterioscler Thromb Vasc Biol 23: 1345-1351, 2003.
10. Grosser N, Abate A, Oberle S, Vreman HJ, Dennery PA, Becker JC, Pohle T, Seidman DS, and Schröder H. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun 308: 956-960, 2003.
11. Grosser N, Hemmerle A, Berndt G, Erdmann K, Hinkelmann U, Schürger S, Wijayanti N, Immenschuh S, and Schröder H. The antioxidant defense protein heme oxygenase-1 is a novel target for statins in endothelial cells. Free Radic Biol Med 37: 2064-2071, 2004.
12. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, and Williams RR. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 16: 250-255, 1996.
13. Lee TS, Chang CC, Zhu Y, and Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110: 1296-1302, 2004.
14. Maines MD. The heme oxygenase system: past, present, and future. Antiox Redox Signal 6: 797-801, 2004.
15. 4 induces heme oxygenase-1 in endothelial cells. Am J Physiol Cell Physiol 289: C557-C563, 2005.
16. 4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J Exp Med 200: 69-78, 2004.
17. Ryter SW, Otterbein LE, Morse D, and Choi AMK. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 234/235: 249-263, 2002.
18. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, and Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987.
19. Verbeugt FW. Aspirin, the poor man's statin? Lancet 351: 227-228, 1998.
20. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, and Figdor CG. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 55: 551-557, 2003.
21. Wallace JL and Fiorucci S. A magic bullet for mucosal protection. . .and aspirin is the trigger! Trends Pharmacol Sci 24: 323-326, 2003.